Follow all Covid precautions even after jab, experts tell kids – ET HealthWorld

Indore: Omicron variant with potential to escape antibodies developed either through natural infection or vaccines could infect vaccinated kids aged 15-18 years, said experts adding to follow precautions. Chest physician MGM Dr Shailesh Agarwal said, “Vaccination isn’t a guarantee for protection against infection. Infection is possible even after vaccination.” “The vaccine however helps in developing immune response for protecting against a virus preventing severity through antibodies”, said Dr Agarwal. “There is also another way through which vaccines help that is cell mediated immunity. It could be developed by vaccination and…

Read More

Serum Institute of India hopes to launch Novavax vaccine for children in six months – ET HealthWorld

The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six months, its CEO said on Tuesday, adding global vaccine supplies were outstripping the absorption capacity of many countries. The Novavax shot, which the world’s largest producer of vaccines calls Covovax, has shown good results in trials in children aged three and older, Adar Poonawalla told a virtual conference organised by the Confederation of Indian Industry. “Our vaccine will be launched in six months,” he said. “It is under trial and…

Read More

We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

NEW DELHI: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the Covid-19 vaccine for children. Dr Ella also said they have almost completed phase two trials for the nasal vaccine and it has shown good results. He said the results of their vaccine for children were “extremely good”. “We have done a clinical trial for gender and age and the results are extremely good, the safety profile is extremely good,…

Read More

Covaxin gets SEC approval: Getting the experts’ perspective – ET HealthWorld

Bharat Biotech’s Covaxin received nod from Subject Expert Committee (SEC) on Tuesday who further proffered positive recommendation to DCGI for the use of Covaxin in 2-18 years age group. Bharat Biotech has earlier submitted data from clinical trials to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for emergency use authorisation (EUA) for the jab at the beginning of this month. If approved by DCGI, Covaxin will become only the second vaccine after Zydus Cadila’s ZyCoV-D to be granted permission for inoculating children in 2-18…

Read More

Children with comorbidities between ages 12 and 17 may get vaccine by October-November – ET HealthWorld

Children with comorbidities may be able to get vaccinated as soon as October-November. Official sources have said to TOI, that children between the ages 12 and 17 that have comorbidities like heart diseases, obesity or immune disorders will be eligible for the vaccine by then. The only vaccine that has the required emergency approval to be used for children in the Zydus Cadila vaccine. Supplies of the vaccine ZyCov-D are likely to begin in October. Zydus Cadila is expected to supply around 30 lakh vaccines in the first lot. After…

Read More

Need to find a common ground with Moderna and Johnson & Johnson for initiating vaccine supply : V K Paul – ET HealthWorld

Discussions are still going on with Moderna and Johnson & Johnson vaccine manufacturers to start their vaccine supplies, though the government has given Emergency Use Authorisation (EUA) for these COVID-19 vaccines, said Dr Vinod K Paul, member of NITI Aayog. It may be noted that the foreign vaccine manufacturers including Pfizer and Moderna have been seeking indemnity against any legal issues if the vaccine may create any serious adverse reactions. Apprising the same in a weekly press briefing on COVID-19 developments in the country, Paul informed that the option for…

Read More

Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO – ET HealthWorld

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. He also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishield production capacity to meet the demand. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes. “The…

Read More